|Home | About | Journals | Submit | Contact Us | Français|
Measles virus (MV), one of the most contagious viruses infecting humans, causes a systemic infection leading to fever, immune suppression, and a characteristic maculopapular rash. However, the specific mechanism or mechanisms responsible for the spread of MV into the respiratory epithelium in the late stages of the disease are unknown. Here we show the crucial role of PVRL4 in mediating the spread of MV from immune to epithelial cells by generating a PVRL4 “blind” recombinant wild-type MV and developing a novel in vitro coculture model of B cells with primary differentiated normal human bronchial epithelial cells. We utilized the macaque model of measles to analyze virus distribution in the respiratory tract prior to and at the peak of MV replication. Expression of PVRL4 was widespread in both the lower and upper respiratory tract (URT) of macaques, indicating MV transmission can be facilitated by more than only epithelial cells of the trachea. Analysis of tissues collected at early time points after experimental MV infection demonstrated the presence of MV-infected lymphoid and myeloid cells contacting respiratory tract epithelium in the absence of infected epithelial cells, suggesting that these immune cells seed the infection in vivo. Thereafter, lateral cell-to-cell spread of MV led to the formation of large foci of infected cells in the trachea and high levels of MV infection in the URT, particularly in the nasal cavity. These novel findings have important implications for our understanding of the high transmissibility of measles.
Measles virus (MV), the prototype morbillivirus of the family Paramyxoviridae, remains a major cause of morbidity and mortality in the developing world and is highly transmissible (1). Recent drops in vaccination rates in Europe have resulted in large-scale outbreaks of measles in a number of countries, with 30,567 cases, 8 deaths, and 27 cases of acute encephalitis reported in 2011 (2). It is estimated that global measles mortality is still above 100,000 cases per year (3). While the epidemiology of measles has been extensively studied and virus transmission is known to take place via the respiratory route, a paucity of data exists on the mechanisms by which MV spreads from person to person.
In contrast to other paramyxoviruses, such as human respiratory syncytial virus (HRSV) and human metapneumovirus, which predominantly infect ciliated epithelial cells in the respiratory tract, MV primarily targets myeloid and lymphoid cells and causes a systemic disease. Spread of virus to respiratory tract tissues following viremia is thought to be a key for MV transmission. Studies showing that the apical side of ciliated epithelial cells is refractory to MV infection showed that these cells are not primary target cells when MV enters the respiratory tract (4, 5). However, the susceptibility of the basolateral side of epithelial cells to MV infection has led to the proposal that MV crosses the airway epithelium by directly infecting epithelial cells in the late stages of the disease (6). Virus budding from the apical cell surface would then enable efficient transmission of virus via respiratory aerosols. The recent identification of PVRL4 (nectin 4) as a cellular receptor for MV on some epithelial cell-lines (7) and subsequent confirmation and extension of this finding to primary differentiated epithelial cells grown on an air-liquid interface (ALI) (8) provided a mechanism through which MV infection of epithelial cells may occur in vivo.
We have previously investigated the early and viremic phases of measles in the macaque model, showing that alveolar macrophages and dendritic cells acted as early targets of MV infection (9–11). In addition, we demonstrated a prominent role for CD150+ lymphocytes and myeloid cells in facilitating the spread of virus to lymphoid tissues throughout the body (9, 10). Moreover, we demonstrated that infection and subsequent depletion of memory T lymphocytes and follicular B lymphocytes may largely explain measles immune suppression (12). In the present study, we have examined the mechanism(s) by which MV crosses the epithelium to emerge into the respiratory tract at and shortly after the peak of infection. We report a critical role for PVRL4 in mediating virus spread from immune to epithelial cells through a novel B-lymphocyte/epithelial cell model and show high levels of epithelial cell infection in the upper respiratory tract (URT), a finding which enhances our understanding of MV transmission.
Two recombinant wild-type MV strains expressing enhanced green fluorescent protein (EGFP) from an additional transcription unit (ATU), rMVIC323EGFP and rMVKSEGFP, validated in the macaque model previously (9, 10, 13), were used in this study to facilitate sensitive macroscopic and microscopic detection of MV infection. An additional virus was generated that does not bind PVRL4 (see below). Virus stocks were generated in an Epstein-Barr virus-transformed human B-lymphoblastic cell line (B-LCL) and were tested to ensure the absence of Mycoplasma species prior to use. Virus titers were obtained by endpoint titration in Vero cells stably expressing human or canine CD150 (Vero-hCD150 and Vero-cCD150, respectively) and were expressed as 50% tissue culture infectious doses (TCID50)/ml using the formula of Reed and Muench (14).
Given that we have recently generated a range of viruses with the ATU in alternative positions in the genome, we extended the name of the virus to “rMVKSEGFP(1)” to reflect these developments. The number in parentheses refers to the genomic position of the ATU. Site-directed mutagenesis was used to introduce two mutations (P497S and P543A) into the open reading frame (ORF) of the hemagglutinin (H) gene in the full-length antigenomic plasmid pMVKSEGFP(1) to generate pMVKSEGFP(1)PVRL4−. This was transfected into Vero-cCD150 cells, previously infected with a recombinant fowlpox virus expressing T7 polymerase (FP-T7), along with helper plasmids encoding the nucleocapsid (N), phospho (P)-, and large (L) proteins of MVKS. The amounts of each plasmid used are as follows: pMVKSEGFP(1)PVRL4−, 10 μg; N, 1 μg; P, 0.6 μg; and L, 0.4 μg. Syncytia were observed 4 to 6 days posttransfection (d.p.t.), and EGFP expression was confirmed by UV microscopy. Cells were scraped into the medium and subjected to one freeze-thaw cycle. Clarified supernatant was used to infect B-LCL. Following two passages in B-LCL, viral titers were determined on Vero-cCD150 or Vero-hCD150 cells and expressed in TCID50/ml.
Normal human bronchial epithelial (NHBE) cells (Lonza, Inc., Walkersville, MD) were differentiated (dNHBE) on type I collagen- and fibronectin-coated 6.5-mm Transwell inserts with a 0.4-μm pore size (Corning, Lowell, MA) using an air-liquid interface as described previously (15). Transepithelial electrical resistance was measured using an STX3 electrode and EVOM meter device (World Precision Instruments) with Transwells used for experiments displaying >800 Ω × cm2. Cells were monitored using a DM IRBE UV microscope (Leica Microsystems), and images were collected using a Leica DM600B microscope equipped with a Leica DFC350 FX digital camera and processed using Leica FW4000 software.
Cells and tissues were collected from cynomolgus macaques (n = 35) and rhesus macaques (n = 5) that were infected with rMVIC323EGFP or rMVKSEGFP and euthanized at 2 (n = 3), 3 (n = 3), 4 (n = 3), 5 (n = 4), 7 (n = 9), 9 (n = 8), 11 (n = 6), 13 (n = 2), or 15 (n = 2) days postinfection (d.p.i.) as reported previously (12). Animals were housed and experiments were conducted in compliance with European guidelines (EU Directive on Animal Testing 86/609/EEC; http://ec.europa.eu/food/fs/aw/aw_legislation/scientific/86-609-eec_en.pdf) and Dutch legislation (Experiments on Animals Act, 1997; http://wetten.overheid.nl/BWBR0003081). The protocols were approved by an independent animal experimentation ethical review committee, and animal welfare was observed on a daily basis. Animal handling was performed under light anesthesia using ketamine and medetomidine. After handling, atipamezole was administered to antagonize the effect of medetomidine.
Animals were euthanized by exsanguination under ketamine/medetomidine anesthesia, and macroscopic foci containing EGFP were visualized and photographed as described previously (10, 13). Samples collected for direct detection of EGFP were collected in freshly prepared 4% (wt/vol) paraformaldehyde (PFA) in phosphate-buffered saline (PBS), while samples required for histological, immunohistochemical, or immunocytochemical analysis were collected in buffered formalin and subsequently blocked in paraffin. Representative blocks from lung and multiple transverse cut blocks from trachea and primary bronchus, nasal septum, and nasal concha, were analyzed.
All formalin-fixed sections were deparaffinized, antigen retrieval was performed, and MV-infected cells were detected as described previously (10) using polyclonal rabbit antibodies to EGFP (Invitrogen) or anti-measles N protein (Novus Biologicals), while PVRL4 present in adherens cell junctions in epithelia was detected using a polyclonal rabbit antibody (Sigma). An Envision peroxidase system with 3,3′-diaminobenzidine (DAB) (Dako) as the substrate was used to detect antigen binding sites. Following assessment of histology and virus immunopathology in respiratory tract tissues, blocks were selected for dual-labeling immunofluorescence performed using polyclonal rabbit antibodies to EGFP (Invitrogen), polyclonal rabbit and monoclonal mouse antibodies to measles N protein together with monoclonal mouse antibodies to the myeloid cell marker CD11c (Novocastra clone no. 5D11), T-lymphocyte marker CD3 (Dako, clone F7.2.38), B-lymphocyte marker CD20 (Dako, clone L26), cell proliferation marker Ki-67 (Dako, clone MIB-1), and an epithelial cytokeratin cell marker (Dako, clone AE1/AE3) or a polyclonal rabbit antibody to PVRL4 (Sigma). Antigen binding sites were detected using anti-mouse rabbit Alexa 488-conjugated and anti-mouse rabbit and human Alexa 568-conjugated antibodies. Following washes to remove unbound antibody, sections were mounted on glass slides using DAPI (4′,6-diamidino-2-phenylindole) HardSet mounting medium (Vector). Selected hematoxylin-and-eosin (H&E)-stained or immunohistochemically stained sections were digitally scanned at high resolution and imaged using PathXL software package (i-Path Diagnostics, Ltd.). Images from immunofluorescence-stained slides were obtained using a fluorescent imaging microscope (Leica Microsystems).
The role of MV-infected immune cells in seeding the infection within respiratory tract epithelial cells was investigated by establishing an in vitro coculture model using human B-LCL and primary dNHBE cells cultured on an ALI. This allowed virus spread to be monitored over time, first from rMV-infected B-LCL to epithelial cells and second from these infected dNHBE cells to neighboring dNHBE cells. B-LCL (104) were infected with rMVKSEGFP(1) at a multiplicity of infection (MOI) of 1 for 24 h. Prior to use in overlay experiments, the rMV-infected B-LCL were rinsed in Dulbecco's phosphate-buffered saline to remove any cell-free virus. Absence of residual virus was confirmed by adding the final washing to Vero-hCD150 cells and incubating the cells for 7 days. MV-infected cells were either overlaid onto the apical surface of intact dNHBE ALI cultures or onto cultures in which the basolateral surface had been exposed by wounding the cells using a pipette tip to scratch the surface of the transwell (Fig. 1A; phase-contrast photomicrograph). Epithelial cells never became infected when rMV-infected B-LCL were overlaid onto the apical surface of the ALI culture (data not shown). Single fluorescent rMVKSEGFP(1)-infected B-LCL adhered to the scratched surface shortly after overlay (Fig. 1A; fluorescence photomicrograph). Spreading of rMVKSEGFP(1) into epithelial cells occurred from 12 h postoverlay (h.p.o.), and small foci of approximately 10 to 15 MV-infected epithelial cells were readily distinguished from adjacent fluorescent B-LCL at 24 h.p.o. (Fig. 1A, arrows). Subsequent MV cell-to-cell spread resulted in progressively larger foci of >100 infected cells at 48 and 72 h.p.o. This demonstrated the importance of cell-to-cell spread in initiating the infection of primary epithelial cells.
A previous study using the wild-type IC323 strain of MV (16) identified residues in the H glycoprotein that are critical for infection of epithelial cells (6). Mutation of amino acids P497F and Y543A abolished entry into epithelial cell lines and did not affect the ability of the virus to use CD150 as a receptor. To prove the generality of this observation, equivalent mutations were introduced into the full-length plasmid pMVKSEGFP (9) to generate pMVKSEGFP(1)PVRL4− (Fig. 1B) and rMVKSEGFP(1)PVRL4− was recovered in Vero-cCD150 cells and passaged twice in B-LCL. Reverse transcription (RT)-PCR and sequence analysis confirmed that the mutations were stably maintained upon virus passage (data not shown). The ability of rMVKSEGFP(1) and rMVKSEGFP(1)PVRL4− to infect a range of cell lines was examined. Both viruses infected CD150-expressing cell lines Vero-cCD150 and B-LCL equivalently (Fig. 1C). The human epithelial cell line NCI-H358 (17) expresses PVRL4 (8), and numerous foci were present when these were infected with rMVKSEGFP(1) (Fig. 1C). When NCI-H358 cells were infected with rMVKSEGFP(1)PVRL4−, only very small numbers of isolated fluorescent cells were detected and there was no cell-to-cell spread. In order to quantify the ability of B-LCL, an A549 cell line stably expressing human CD150 (A549-hCD150), and the NCI-H358 cell line to support infection, they were infected in triplicate with both viruses and supernatants were harvested at 2 d.p.i. (B-LCL and A549-hCD150) or 3 d.p.i. (NCI-H358). The titer of released virus was determined on Vero-cCD150 cells, and equivalent amounts of virus were obtained when the viruses were grown on CD150-expressing cell lines (Fig. 1D). NCI-H358 cells generated 100 times less rMVKSEGFP(1) than CD150-expressing cells, and no progeny virus was recovered from rMVKSEGFP(1)PVRL4−-infected NCI-H358 cells.
Ubiquitous expression of PVRL4 on the surface of a cell does not reflect the in vivo situation in which the molecule is localized within the adherens junction. Furthermore, cell-associated rather than cell-free virus is the form in which the infectivity is transmitted from an immune to an epithelial cell, making the in vitro coculture model ideal for the study of this late-stage event in MV pathogenesis. B-LCL (104) were infected with rMVKSEGFP(1)PVRL4− and overlaid onto wounded dNHBE cells (Fig. 1E; phase-contrast photomicrograph) as described above. Although the MVKSEGFP(1)PVRL4−-infected B-LCL adhered to the scratch equivalently (Fig. 1E; fluorescent photomicrograph), the infectivity was not transferred to the epithelial cells. Small numbers of rMVKSEGFP(1)PVRL4−-infected B-LCL remained at 24 and 48 h.p.o. In rare instances, foci comprised of 2 or 3 infected epithelial cells apparently were observed at 72 h.p.o. (Fig. 1E, arrow).
Formalin-fixed and paraffin-embedded dNHBE cells were used to test a number of commercial antibodies to PVRL4. Upon identification of a polyclonal antibody that met our criteria for acceptable levels of background staining and a staining pattern consistent with our understanding of spatial PVRL4 expression as a component of the adherens junction within epithelia (Fig. 2A), this antibody was used to examine the PVRL4 distribution in a large number of respiratory tract tissues from uninfected and MV-infected macaques. Prior to use, the specificity of the antibody was verified and optimized by immunocytochemical staining of PVRL4 along the membrane of CHO-K1 cells transfected with a plasmid expressing human PVRL4, while negative staining was observed in cells transfected with an empty vector control plasmid (data not shown). High levels of PVRL4 expression were observed in the nonkeratinized stratified squamous epithelia of the tonsil, with strong PVRL4 expression observed around the cell membrane of epithelial cells (Fig. 2B). An analogous PVRL4 staining pattern was observed in focal areas of tongue epithelium (Fig. 2C). In contrast, a more irregular polarized staining pattern was observed in nasal concha epithelia in the URT and tracheal epithelia in the lower respiratory tract (LRT), in which PVRL4 was mainly detected along the basolateral surface of pseudostratified columnar epithelial cells (Fig. 2D and andE).E). High levels of PVRL4 expression were also observed in the lung, especially in epithelial cells surrounding the lumen of the bronchi (Fig. 2F).
The spread of MV within respiratory tract tissues of macaques was examined at different time points postinfection with wild-type rMV strains expressing EGFP. This permitted targeted pathological assessment allowing the optimal selection and blocking of samples for formalin fixation, paraffin embedding, and microtome sectioning. Extensive EGFP fluorescence, indicative of MV infection, was visible throughout the respiratory tract at the peak of infection at 9 d.p.i. Foci of MV infection were visible in all lobes of the lung (Fig. 3A) and along the entire length of the trachea (Fig. 3B). Microscopic examination of the inner surface of intact trachea rings obtained from animals at the peak of infection revealed circular foci of MV-infected epithelial cells (Fig. 3C). These may arise via the lateral spread of virus within the epithelium following initial infection of an epithelial cell, akin to virus cell-to-cell spread in vitro (compare with Fig. 1A). Examination of transverse sections through the nose facilitated the detection of very large numbers of infected cells in the nasal concha and, even more extensively, in the adjacent nasal mucosa (Fig. 3D). Live cell confocal scanning laser microscopy of the unfixed, unprocessed nasal concha collected directly from infected animals at necropsy revealed irregularly shaped foci of morphologically identifiable infected epithelial cells on the surface of the tissue (Fig. 3E), illustrating the lateral spread of MV between epithelial cells once infection is established in the epithelium. Individual foci of infection were also detected in the epithelium of the nasal septum (data not shown). This mirrors what was modeled in vitro using B-LCL and dNHBE cells (Fig. 1A).
Respiratory tract tissue sections were examined at 7 d.p.i., 1 or 2 days prior to the peak of viremia, to assess how MV spreads into respiratory tract epithelial cells. While a low level of epithelial cell infection was observed in most respiratory tract tissues (data not shown), an observation we have previously reported at this time point (5, 10), immune cells were the predominant MV-infected cell lineage present in respiratory tract epithelia at this time point. Low levels of MV-infected immune cells were present in close proximity to tracheal epithelium, with leukocytes or cellular processes interdigitating into the epithelium from underlying infected myeloid cells spanning the basement membrane, providing a route of virus entry into epithelial cells (Fig. 4A and andB).B). The absence of MV-infected epithelial cells at many of these sites at this time point suggests that infiltration of infected immune cells or alternatively infection of resident immune cells in respiratory tract epithelium is an inherent pathological feature of MV infection and is not occurring in response to MV infection of epithelial cells. Limited lateral spread of virus within the epithelium resulted in small foci of infected tracheal pseudostratified ciliated columnar epithelial cells by 9 d.p.i. (Fig. 4C). CD11c+ myeloid cells were present in the lamina propria beneath tracheal epithelium (Fig. 4D), with CD3+ T cells observed in close proximity to MV-infected epithelial cells (Fig. 4E). Uninfected and infected CD20+ B cells were present within bronchial epithelium, especially in areas overlying large aggregates of lymphoid tissue (Fig. 4F).
Spread of virus from immune cells resulted in MV infection of ciliated pseudostratified columnar epithelial cells. Dual labeling for MV N protein and cytokeratin showed accumulation of N protein underneath the apical membrane of MV-infected epithelial cells and an absence of infection in cytokeratin-positive cells present within lower layers of the epithelium (Fig. 5A). Further analysis of the differential susceptibility of tracheal epithelial cells to MV infection by dual labeling with EGFP and Ki-67, a marker of cellular proliferation, demonstrated that MV-negative epithelial cells present in basal cell layers of the epithelium stain positive for Ki-67 and thus represent a population of uninfected proliferating epithelial cells (Fig. 5B). Analysis of PVRL4 distribution showed that highest expression levels were present at the cell boundaries of basal tracheal epithelial cells, with no discernible concomitant downregulation of PVRL4 expression visible within large foci of MV-infected cells (Fig. 5C).
High levels of MV-infected cells were present in the nasal cavity of MV-infected macaques at the peak of infection (Fig. 3D), indicating a key role for nasal epithelium in MV transmission. Examination of a transverse section through the nasal concha revealed high levels of epithelial cell infection and epithelial damage due to shedding of these cells into the lumen (Fig. 5D). In the nasal mucosa, MV mainly infected ciliated pseudostratified columnar epithelial cells, with contiguous epithelial cell infection and exfoliation of MV-infected epithelial cells into the nasal cavity observed as characteristic features of the infection in the URT (Fig. 5E and andF).F). In common with the distribution of MV-infected cells in tracheal epithelium, no positive immunostaining was observed in nonciliated basal epithelial cells present in lower levels of the epithelium. Although cell-to-cell fusion was observed in large foci of MV-infected epithelial cells, as evidenced by some degree of clustering of the nuclei (Fig. 5G), limited immune cell infiltration or disruption of the epithelium was apparent.
In contrast to infections caused by respiratory pathogens such as HRSV, seasonal influenza virus strains, and rhinoviruses, MV spreads systemically and infection of respiratory tract tissues occurs predominantly in the late stages of the disease. The identification of MV-infected cells or tissues in the URT and LRT of infected individuals contributing to MV transmission has historically proven difficult to assess, due to a paucity of published pathological studies from human measles cases which made use of a set of diverse tissue blocks free of complications caused by underlying disease or secondary bacterial infections. With the macaque being an established natural model of measles, we undertook a comprehensive analysis of the respiratory tract of MV-infected macaques to analyze the mechanism through which MV spreads into respiratory epithelium in the late stages of the disease, complementing our studies into early events in measles pathogenesis (9). The availability of tissue blocks from the respiratory tract of a large number of MV-infected animals (n = 40) adds weight to the conclusions from this study.
Analysis of respiratory tract tissues from MV-infected macaques highlighted the crucial role of MV-infected immune cells in the spread of virus to epithelial cells. Although long assumed, this is the first evidence of immune cells having a direct role in the spread of MV into epithelia in vivo and thus completes a missing link in our understanding of measles pathogenesis. A recent study also proposed a role for myeloid cells in the lamina propria of the trachea in spreading virus to the epithelium (18). However, MV-infected lymphocytes were not detected within epithelium and dual-labeling immunofluorescence stains were not performed. The in vitro model we have developed will be invaluable for others in understanding the importance of cell-to-cell transmission of paramyxoviruses. MV spread into epithelia is most likely mediated via the interaction of MV glycoprotein complexes on the surface of immune cells with PVRL4, which we show to be present in epithelial cell adherens junction in a wide array of tissues, including lung, bronchi, trachea, and nasal concha. This provides a mechanism through which MV can access a cellular receptor that is inaccessible to virus present in the lumen of the respiratory tract, due to its spatial localization within epithelia, and allows MV infection of epithelial cells in tissues of both the LRT and URT. Interestingly, polarized expression of PVRL4 was observed along the basolateral surface of pseudostratified ciliated epithelial cells in the trachea and nasal concha. The fact that MV infection is primarily restricted to nondividing (Ki-67-negative) pseudostratified columnar ciliated epithelial cells in tracheal epithelium, despite high levels of PVRL4 expression in dividing (Ki-67-positive) basal epithelial cells, suggests that additional host factors or the context through which such cells are contacted by MV-infected immune cells may influence the susceptibility of tracheal epithelial cells to MV infection.
We have previously reported the utility of rMV expressing fluorescent proteins to monitor virus cell-to-cell spread sensitively in vitro in both neural and primary epithelial cells (5, 19). In this study, we have applied these techniques to a novel in vitro coculture model and show rapid virus spread from MV-infected B cells to adjacent primary differentiated bronchial epithelial cells in which the adherens junctions were rendered accessible by cell wounding. This proves that immune cells are capable of transferring MV infectivity into respiratory epithelium. The key role of PVRL4 in governing MV cell-to-cell spread from immune cells to epithelial cells in this model is highlighted by the fact that an rMV strain unable to bind to PVRL4 was restricted to B-LCL. The location of PVRL4 at adherens cell junctions of epithelial cells means that this molecule is inaccessible to cell-free virus present at the apical side. Thus, we propose that MV infection of epithelial cells primarily occurs via cell-to-cell fusion between resident or infiltrating MV-infected immune cells and PVRL4+ epithelial cells rather than virus-to-cell fusion. Further research is required using model systems in which PVRL4 is expressed in its normal architectural location rather than overexpression in continuous cell lines in order to gain a more complete understanding of the differences between these two modes of virus spread and ultimately their relevance to virus spread in vivo.
Recently, the trachea has been proposed as the primary site from which MV emerges into the airways of the respiratory tract prior to transmission to a susceptible host (8, 20). However, our analysis of MV infection and related pathology of respiratory tract epithelia presents a more complex picture. While we detected large circular foci of MV-infected ciliated epithelial cells along the inner surface of the trachea, the overall burdens of MV infection and associated lesions were lower than those of the nasal concha and mucosa in the nasal cavity, in which strong PVRL4 expression in epithelia was also observed. The anatomical location of these tissues means that virus shed from these sites is inherently more likely to be expelled into the environment by airflow than virus emerging lower in the airways, which has to survive neutralization for a longer time period by host factors present in mucus and saliva. A number of other viruses transmitted via the respiratory route are known to infect the URT, including HRSV, coronaviruses, and rhinoviruses (21–23). In the case of Sendai virus, transmission of virus from infected animals was directly associated with infection of the URT and was independent of infection in the lung (24). Conversely, H5N1 strains of influenza cause significant disease in humans with high case fatality rates, but usually remain restricted to the initial index patient due to the fact that the virus replicates mostly in the LRT (25, 26). While the cough reflex typically associated with measles is triggered by stimulation of sensory nerves at or below the level of the larynx, URT infections can also trigger a productive cough due to nonspecific effects of inflammatory mediators and increased mucus production on sensory nerve endings in the bronchi and trachea in the LRT (22).
In summary, we propose a mechanism for the introduction of MV into the respiratory epithelium following viremia, via the infiltration of MV-infected immune cells and subsequent spread to PVRL4-positive pseudostratified columnar epithelium, and demonstrate an analogous mode of cell-to-cell spread in a novel in vitro coculture model of respiratory epithelium. Differential levels of MV infection were observed in epithelium from different respiratory tract tissues, with nasal epithelium in the URT consistently displaying a high level of infection. This emerging view of the late stages of measles pathogenesis should lead to further experiments focused on the aerosolized transmission of morbilliviruses.
We thank the staff of the Tissue Core Technology Unit and the Bioimaging Unit, QUB, for expert technical assistance, Yusuke Yanagi for providing the Vero-hCD150 and A549-hCD150 cell lines and the plasmid from which the rMVIC323EGFP virus was rescued, and Thijs Kuiken and Bert Rima for helpful discussions. In addition, we thank Robert Dias D'Ullois, Tien Nguyen, and Linda Rennick for their contributions to these studies.
This work was funded by MRC grant no. G0801001 and ZonMw grant no. 91208012.
The funding agencies had no role in study design, data collection, and analysis or the decision to publish or preparation of the manuscript.
Published ahead of print 30 January 2013